Quarterly report pursuant to Section 13 or 15(d)

Business (Details)

v3.24.2.u1
Business (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 28, 2024
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Debt Instrument [Line Items]              
Net loss     $ (98,463) $ 8,193 $ 22,827 $ 18,148  
Net cash used in operating activities         22,485 21,078  
Cash and cash equivalents     93,426 6,307 93,426 6,307 $ 7,415
Proceeds from sale of shares pursuant to common stock private placement, net         115,625 0  
Accumulated deficit              
Debt Instrument [Line Items]              
Net loss     (98,463) $ 8,193 22,827 $ 18,148  
Private Placement              
Debt Instrument [Line Items]              
Proceeds from sale of shares pursuant to common stock private placement, net $ 108,100 $ 108,100          
Private Placement | Preferred Stock              
Debt Instrument [Line Items]              
Net proceeds 115,600 $ 115,600          
Private Placement | Warrant liability              
Debt Instrument [Line Items]              
Fair value of warrant $ 69,400   $ 69,400   $ 69,400